Clinical Trials on Breast Asymmetry, 3D in New Zealand
Total 2132 results
-
Weill Medical College of Cornell UniversityWithdrawn3D Transesophageal and Transthoracic EchocardiogramUnited States
-
Provectus PharmaceuticalsCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Danish Cancer SocietyRegion SjællandActive, not recruiting
-
University of Auckland, New ZealandCompletedBreast Cancer | Chemotherapy-induced Nausea and Vomiting | OncologyNew Zealand
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.TerminatedStomach Neoplasms | Breast NeoplasmsAustralia, New Zealand
-
Zealand University HospitalCopenhagen University Hospital, DenmarkCompletedBreast Cancer | Ductal Carcinoma in SituDenmark
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | Fatigue | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentBelgium, Switzerland, United Kingdom, Australia, Italy, New Zealand
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | OsteoporosisFrance, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Ontario Clinical Oncology Group (OCOG)U.S. Army Medical Research and Development Command; Supportive Cancer Care...Completed
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel, Spain, Australia, Canada, New Zealand, United Kingdom, France, Tunisia
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research...CompletedBreast CancerCanada, Australia, New Zealand
-
National Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Male Breast CarcinomaUnited States
-
Unity Health TorontoRoche Pharma AGCompletedDyspnea | Acute Heart Failure | Shortness of BreathCanada, United States, New Zealand
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedInflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast Carcinoma | Mucinous Ductal Breast Carcinoma | Papillary Ductal Breast Carcinoma | Tubular Ductal Breast CarcinomaUnited States
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Breast Neoplasms | Breast AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer StageUnited States
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene MutationUnited States
-
Columbia UniversityCompletedBreast Cancer | Breast Tumors | Cancer of BreastUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Residual Disease | HER2 Positive Breast CarcinomaUnited States
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
Rutgers, The State University of New JerseyTerminatedBreast Cancer | Resistance TrainingUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
Vardhman Mahavir Medical College And Safdarjung...Completed
-
Samsung MedisonUniversity of RochesterUnknownBreast Cancer | Breast Lesions | Breast MassUnited States
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaboratorsCompletedBreast Cancer | Infertility | Menopausal SymptomsItaly, Australia, Switzerland, Belgium, Hungary, New Zealand